Use of the anti-idiotype antibody vaccine TriAb after autologous stem cell transplantation in patients with metastatic breast cancer.
Reece, D E
Use of the anti-idiotype antibody vaccine TriAb after autologous stem cell transplantation in patients with metastatic breast cancer. [electronic resource] - Bone marrow transplantation Oct 2000 - 729-35 p. digital
Publication Type: Journal Article
0268-3369
10.1038/sj.bmt.1702607 doi
Adult
Aged
Antibodies, Anti-Idiotypic--therapeutic use
Antigens, Neoplasm--immunology
Antineoplastic Combined Chemotherapy Protocols--immunology
Bone Neoplasms--immunology
Breast Neoplasms--immunology
Cancer Vaccines--immunology
Disease-Free Survival
Female
Follow-Up Studies
Hematopoietic Stem Cell Transplantation
Humans
Immunotherapy
Liver Neoplasms--immunology
Lymphatic Metastasis--immunology
Lymphocyte Activation
Middle Aged
Time Factors
Transplantation, Autologous
Treatment Outcome
Use of the anti-idiotype antibody vaccine TriAb after autologous stem cell transplantation in patients with metastatic breast cancer. [electronic resource] - Bone marrow transplantation Oct 2000 - 729-35 p. digital
Publication Type: Journal Article
0268-3369
10.1038/sj.bmt.1702607 doi
Adult
Aged
Antibodies, Anti-Idiotypic--therapeutic use
Antigens, Neoplasm--immunology
Antineoplastic Combined Chemotherapy Protocols--immunology
Bone Neoplasms--immunology
Breast Neoplasms--immunology
Cancer Vaccines--immunology
Disease-Free Survival
Female
Follow-Up Studies
Hematopoietic Stem Cell Transplantation
Humans
Immunotherapy
Liver Neoplasms--immunology
Lymphatic Metastasis--immunology
Lymphocyte Activation
Middle Aged
Time Factors
Transplantation, Autologous
Treatment Outcome